Definitions

As used in this subchapter: The term “administer” refers to the direct application of a controlled substance to the body of a patient or research subject by— The term “depressant or stimulant substance” means— The terms “marihuana” and “marijuana” do not include— The term “narcotic drug” means any of the following whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis: The term “immediate precursor” means a substance— The term “serious bodily injury” means bodily injury which involves— Except as provided in subparagraph (C), the term “controlled substance analogue” means a substance— Such term does not include— The term “list I chemical” means a chemical specified by regulation of the Attorney General as a chemical that is used in manufacturing a controlled substance in violation of this subchapter and is important to the manufacture of the controlled substances, and such term includes (until otherwise specified by regulation of the Attorney General, as considered appropriate by the Attorney General or upon petition to the Attorney General by any person) the following: The term “list II chemical” means a chemical (other than a list I chemical) specified by regulation of the Attorney General as a chemical that is used in manufacturing a controlled substance in violation of this subchapter, and such term includes (until otherwise specified by regulation of the Attorney General, as considered appropriate by the Attorney General or upon petition to the Attorney General by any person) the following chemicals: The term “regulated transaction” means— a distribution, receipt, sale, importation, or exportation of, or an international transaction involving shipment of, a listed chemical, or if the Attorney General establishes a threshold amount for a specific listed chemical, a threshold amount, including a cumulative threshold amount for multiple transactions (as determined by the Attorney General, in consultation with the chemical industry and taking into consideration the quantities normally used for lawful purposes), of a listed chemical, except that such term does not include— any transaction in a listed chemical that is contained in a drug that may be marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], subject to clause (v), unless— The term “anabolic steroid” means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone), and includes— androstanediol— androstenediol— androstenedione— norandrostenediol— norandrostenedione— Subject to clause (ii), a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed in subparagraph (A) and is derived from, or has a chemical structure substantially similar to, 1 or more anabolic steroids listed in subparagraph (A) shall be considered to be an anabolic steroid for purposes of this chapter if— the drug or substance has been created or manufactured with the intent of producing a drug or other substance that either— A substance shall not be considered to be a drug or hormonal substance for purposes of this subparagraph if it— is— The terms “broker” and “trader” mean a person that assists in arranging an international transaction in a listed chemical by— The term “scheduled listed chemical product” means, subject to subparagraph (B), a product that— For purposes of this paragraph, entities are defined by reference to the Standard Industrial Classification (SIC) code, as follows: The term “online pharmacy”— does not include— a pharmacy registered under section 823(g) of this title whose dispensing of controlled substances via the Internet consists solely of— The term “practice of telemedicine” means, for purposes of this subchapter, the practice of medicine in accordance with applicable Federal and State laws by a practitioner (other than a pharmacist) who is at a location remote from the patient and is communicating with the patient, or health care professional who is treating the patient, using a telecommunications system referred to in section 1395m(m) of title 42, which practice— is being conducted— by a practitioner— registered under section 823(g) of this title in the State in which the patient is located, unless the practitioner— is— is being conducted while the patient is being treated by, and in the physical presence of, a practitioner— registered under section 823(g) of this title in the State in which the patient is located, unless the practitioner— is— is being conducted by a practitioner— is being conducted— in a medical emergency situation— by a practitioner that— The term “refilling prescriptions for controlled substances in schedule III, IV, or V”— The term “filling new prescriptions for controlled substances in schedule III, IV, or V” means filling a prescription for an individual for a controlled substance in schedule III, IV, or V, if— The term “suspicious order” may include, but is not limited to— The term “serious drug felony” means an offense described in section 924(e)(2) of title 18 for which— The term “serious violent felony” means—